2024’s Busiest Dealmakers: Novartis Laps The Field, While Lilly, Sanofi Keep Busy

Novartis Joined By Roche, Novo Nordisk For Highest BD Spending

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.